It is well documented that chronic kidney disease patients have an extremely high risk of developing cardiovascular (CV) disease (CVD) compared to the general population. Declining renal function itself represents a continuum of CV risk, and in those individuals who survive to reach end-stage renal disease, the risk of suffering a cardiac event is uncomfortably and unacceptably high. Several pathophysiological pathways have been suggested to account for this, including endothelial dysfunction, dyslipidemia, inflammation, left ventricular hypertrophy, troponins, phosphate, vitamin D, fibroblast growth factor-23, and NT-proBNP. All these conditions and biomarkers may have clear associations with current and subsequent CVD.
The Cardiovascular Burden in End-Stage Renal Disease / M. Cozzolino, A. Galassi, F. Pivari, P. Ciceri, F. Conte. - In: CONTRIBUTIONS TO NEPHROLOGY. - ISSN 0302-5144. - 191(2017), pp. 44-57.
The Cardiovascular Burden in End-Stage Renal Disease
M. CozzolinoPrimo
;F. Pivari;P. CiceriPenultimo
;
2017
Abstract
It is well documented that chronic kidney disease patients have an extremely high risk of developing cardiovascular (CV) disease (CVD) compared to the general population. Declining renal function itself represents a continuum of CV risk, and in those individuals who survive to reach end-stage renal disease, the risk of suffering a cardiac event is uncomfortably and unacceptably high. Several pathophysiological pathways have been suggested to account for this, including endothelial dysfunction, dyslipidemia, inflammation, left ventricular hypertrophy, troponins, phosphate, vitamin D, fibroblast growth factor-23, and NT-proBNP. All these conditions and biomarkers may have clear associations with current and subsequent CVD.| File | Dimensione | Formato | |
|---|---|---|---|
|
ContributionNephrology2017CV.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
132.13 kB
Formato
Adobe PDF
|
132.13 kB | Adobe PDF | [it] Default value: Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in AIR sono rilasciati con licenza CCO mentre i file delle pubblicazioni sono rilasciati con licenza CC BY-SA, salvo diversa indicazione. In caso di violazione di copyright, contattare l'assistenza di AIR




